Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Carlos Zala, MD
Vacunar, Sede Las Cañitas, Buenos Aires, Argentina, Argentina
Poster(s):
(P-711) Persistence of Immunogenicity and Safety of the Respiratory Syncytial Virus Prefusion F Protein Vaccine (RSVPreF3 OA) Administered to Adults 50–59 Years of Age (YOA)
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT